DP
Debarati Paul
About Debarati Paul
Data last updated:
Debarati Paul is a Director at Symbio Scientific Private Limited (since 2011) and Director at Evolics Bio Private Limited (since 2021). The companies operate in Healthcare and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹17.00 Cr; the largest is Symbio Scientific Private Limited at ₹15.40 Cr (FY 2025). Earlier, Debarati Paul was an Additional Director at Vidaboat Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Dec 2011 | 2011 | ₹15.40 Cr (FY 2025) | Active | |
| Director | 12 Oct 2021 | 2019 | ₹1.61 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 20 Apr 2019 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Debarati Paul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Susanta Paul | 05103972 | Symbio Scientific Private Limited , Evolics Bio Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Debarati Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Debarati Paul
Debarati Paul currently holds 2 directorships: Symbio Scientific Private Limited (Director, since 13 Dec 2011, revenue ₹15.40 Cr (FY 2025)); Evolics Bio Private Limited (Director, since 12 Oct 2021, revenue ₹1.61 Cr (FY 2025)).
Debarati Paul was first appointed on 13 Dec 2011 as Director at Symbio Scientific Private Limited. The most recent appointment on record is 12 Oct 2021 at Evolics Bio Private Limited.
The 2 current companies of Debarati Paul that report revenue have a combined latest revenue of ₹17.00 Cr: Symbio Scientific Private Limited ₹15.40 Cr (FY 2025); Evolics Bio Private Limited ₹1.61 Cr (FY 2025).
Debarati Paul held 1 earlier board appointment: Vidaboat Private Limited (Additional Director, from 20 Apr 2019).
The current boards of Debarati Paul's companies include Susanta Paul (Symbio Scientific Private Limited).